Novel catalase loaded nanocores for the treatment of inflammatory bowel diseases

References

• Ambati J, Lopez AM, Cochran D, Wattamwar P, Bean K, Dziubla TD, et al. 2012. Engineered silica nanocarriers as a high-payload delivery vehicle for antioxidant enzymes. Acta Biomaterialia. 10:2096–2103.
   Web of Science ®Google Scholar
• Balmus IM, Ciobica A, Trifan A, Stanciu C. 2016. The implications of oxidative stress and antioxidant therapies in inflammatory bowel disease: clinical aspects and animal models. Saudi J Gastroenterol. 22:3.
   PubMed Web of Science ®Google Scholar
• Carmen SD, LeBlanc ADMD, Martin R, Chain F, Langella P. 2014. Genetically engineered immunomodulatory streptococcus thermophilus strains producing antioxidant enzymes exhibit enhanced anti-inflammatory activities. Appl Environ Microbiol. 80:869–877.
   PubMed Web of Science ®Google Scholar
• Cui Z, Yin J, Wang L, He L, Yin Y, Li T. 2016. Effects of pro-inflammatory cytokines and antioxidants expression in the jejunum of mice induced by hydrogen peroxide. Int Immunopharmacol. 31:9–14.
   PubMed Web of Science ®Google Scholar
• Farihurst D. 2013. An Overview of the Zeta Potential Part 3: Uses and Applications. Fishers (IN): American Pharmaceutical Reviews.
   Google Scholar
• Goyal AK, Khatri K, Mishra N. 2009. Development of self-assembled nanoceramic carrier construct(s) for vaccine delivery. J Biomater Appl. 24:65–84.
   PubMed Web of Science ®Google Scholar
• Greenwald RA. 1990. Superoxide dismutase and catalase as therapeutic agents for human diseases. A critical review. Free Radic Biol Med. 8:201–209.
   PubMed Web of Science ®Google Scholar
• Ibrahim RY, Hassan AI, AL-Adham EK. 2015. The anti-ulcerative colitis effects of Annona squamosa Linn. leaf aqueous extract in experimental animal model. Int J Clin Exp Med. 8:21861–21870.
   PubMed Web of Science ®Google Scholar
• Ishikawa K, Ducheyne P, Radin S. 1993. Detemination of the Ca/P ratio in calcium-deficient hydoxyapatite using X-ray differaction analysis. J Mater Sci Mater Med. 4:165–168.
   Web of Science ®Google Scholar
• Jin Y, Yang J, Lin L, Lin Y, Zheng C. 2016. The attenuation of Scutellariae radix extract on oxidative stress for colon injury in lipopolysaccharide-induced RAW264.7 Cell and 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis rats. Pharmacogn Mag. 12:153.
   PubMed Web of Science ®Google Scholar
• Kossovsky N, Gelman A, Sponsler EE. 1994. Cross linking encapsulated haemoglobin solid phase supports: lipid enveloped haemoglobin adsorbed to surface modified ceramic particles exhibit physiological oxygen lability. Artif Cells Blood Substit Immobil Biotechnol. 22:479–485.
   PubMed Web of Science ®Google Scholar
• Kruidenier L, Kuiper I, Lamers CB, Verspaget HW. 2000. Intestinal oxidative damage in inflammatory bowel disease: semiquantification, localization, and association with mucosal antioxidants. J Pathol. 201:28–36.
   Web of Science ®Google Scholar
• Kumagi S, Jikimoto T. 2003. Pathological roles of oxidative stress in autoimmune diseases. Rinsho Byori. 2:126–132.
   Google Scholar
• Lee KY, Mooney DJ. 2012. Alginate: properties and biomedical applications. Prog Polym Sci. 37:106–126.
   PubMed Web of Science ®Google Scholar
• Loukas YL, Gregoriadis G, Vraka V. 1997. Novel non-acidic formulation of haloperidol complexed with beta-cyclodextrin derivatives. J Pharm Biomed Anal. 2:263–268.
   Web of Science ®Google Scholar
• Mc Cole DF, Barrett KE. 2008. Acute treatment of isolated colon with the hydrogen peroxide scavenger, catalase, alleviates ion transport dysfunction in murine DSS colitis. FASEB J. 22:1189.
   Web of Science ®Google Scholar
• Moura FA, de Andrade KQ, dos Santos JCF, Araujo ORP, Goulart MOF. 2015. Antioxidant therapy for treatment of inflammatory bowel disease: Does it work? Redox Biol. 6:617–639.
   PubMed Web of Science ®Google Scholar
• Pandey RS, Sahu S, Sudheesh MS, Madan J, Kuma M, Dixit V. 2011. Carbohydrate modified ultrafine ceramic nanoparticles for allergen immunotherapy. Int Immunopharmacol. 11:925–931.
   PubMed Web of Science ®Google Scholar
• Patil S, Pancholi SS, Agrawal S, Agrawal GP. 2004. Surface-modified mesoporous ceramics as delivery vehicle for haemoglobin. Drug Deliv. 3:193–199.
   Web of Science ®Google Scholar
• Peppas NA. 1985. Analysis of fickian and non-fickian drug release from polymers. Pharm Acta Helv. 60:110–111.
   PubMedGoogle Scholar
• Poinern G, Brundavanam R, Fawcett D. 2013. Nanometre scale hydroxyapatite ceramics for bone tissue engineering. Am J Biomed Eng. 6:48–168.
   Google Scholar
• Poinern GE, Brundavanam RK, Mondinos N, Jiang ZT. 2009. Synthesis and characterisation of nanohydroxyapatite using an ultrasound assisted method. Ultrason Sonochem. 16:469–475.
   PubMed Web of Science ®Google Scholar
• Rana SV, Sharma S, Prasad KK, Sinha SK, Singh k. 2014. Role of oxidative stress & amp; antioxidant defence in ulcerative colitis patients from north India. Indian J Med Res. 139:568–571.
   PubMed Web of Science ®Google Scholar
• Rawat M, Singh D, Saraf S, Saraf S. 2006. Nanocarriers: promising vehicle for bioactive drugs. Biol Pharm Bull. 29:1790–1798.
   PubMed Web of Science ®Google Scholar
• Rawat M, Singh D, Saraf S, Saraf S. 2008. Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme. Drug Dev Ind Pharm. 34:181–188.
   PubMed Web of Science ®Google Scholar
• Rezaie A, Parker RD, Abdollahi M. 2007. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci. 52:2015–2021.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Peppas NA. 2001. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 48:139–157.
   PubMed Web of Science ®Google Scholar
• Singh D, Dubey P, Pradhan M, Singh MS. 2013. Ceramic nanocarriers: versatile nanosystem for protein and peptide delivery. Expert Opin Drug Deliv. 10:241–259.
   PubMed Web of Science ®Google Scholar
• Singh D, Srivastava S, Pradhan M, Kanwar JR, Singh MR. 2015. Inflammatory bowel disease: pathogenesis, causative factors, issues, drug treatment strategies, and delivery approaches. Crit Rev Ther Drug Carrier Syst. 32:181–214.
   PubMed Web of Science ®Google Scholar
• Zhang YZ, Yong YL. 2014. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 20:91–99.
   PubMed Web of Science ®Google Scholar